drugset / Trial / NCT05118984
Efficacy of Azithromycin in MSAF Cases to Improve Maternal and Neonatal Outcomes
RandomizedParallel-groupDouble-blindPrevention
Summary
Meconium stained amniotic fluid increases the risk of maternal complications (e.g., dystocia, operative delivery, and postpartum endometritis) and neonatal complications (e.g., sepsis, admission to the neonatal intensive care unit \[NICU\], and meconium aspiration syndrome). The goal of the study is to compare between Azithromycin vs Placebo in cases of meconium stained amniotic fluid during the first stage of labor in multigravida women and their effect on maternal and neonatal outcomes.
Timeline
- Start
- 2021-02-16
- Primary completion
- 2021-05-31
- Completion
- 2021-10-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Azithromycin | Small molecule | 250 mg | — |